HealthMyne’s Radiomic Technology Leveraged to Identify Biomarkers That Predict Immunotherapy Treatment Responses

MADISON, Wis., Sept. 21, 2021 /PRNewswire/ — HealthMyne, a pioneer in applied radiomics, announced today that peer-reviewed research recently published in the journal Cancers has demonstrated the ability of its radiomics technology to identify biomarkers that predict whether patients…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.